Morgan Petronelli

Take a look inside Suneel Chilukuri, MDs, Refresh Dermatology practice as he discusses patient retention and demonstrates his QWO cellulite treatment protocol in office.

Suneel Chilukuri, MD, FAAD, FACMAS, takes Dermatology Times inside his practice, Refresh Dermatology located in Houston, Texas, to demonstrate how they separate themselves from competitors.

The FDA has approved a single-dose pre-filled pen for dupilumab (Dupixent, Sanofi and Regeneron) for at-home administration.

The National Psoriasis Foundation has updated its guidance statements for individuals living with psoriatic disease during the COVID-19 pandemic.

A study found WaterWipes, a baby wipe comprised of 99.9% water and a drop of fruit extract, helped reduce facial pressure injuries (FPI) caused by prolonged wear of personal protective equipment (PPE).

ICYMI, some of this week’s featured content includes a new podcast episode, as well as articles on treating skin conditions in Asian patients, the newest FDFA approvals, acne treatment updates from AAD, and more.

This week’s edition of The Mainstream Patient features stories about microcurrent facials, the psoriasis treatment journey, melanoma survivor stories, plus more.

Mallinckrodt announces the FDA approval of StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns.

We dive into how health care policy impacts gender and sexual minority patients, including exploring the Affordable Care Act (ACA) and Medicaid expansion, and identifying state and federal nondiscrimination protections that help defend equal access to health care for this patient population.

This episode dives into how health care policy impacts gender and sexual minority patients, including exploring the Affordable Care Act (ACA) and Medicaid expansion, and identifying state and federal nondiscrimination protections that help defend equal access to health care for this patient population.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, tips and resources for maintaining your mental health as a gender and sexual minority.

In this video interview, Ted Lain, MD, discusses the causes and effects of actinic keratosis, as well as the unmet needs, how to diagnose, and what treatments are currently available.

In this exclusive interview, Ted Lain, MD, dives into the management of field cancerization, including its biggest challenges, available and emerging treatment options, tips on treatment approach, and more.

ICYMI, some of this week’s featured content includes new treatment guidelines for AK, health care impacts on gender and sexual minority patients, upadacitinib for atopic dermatitis, plus more

Emma Guttman-Yassky, MD, sits down with Dermatology Times® to discuss recently published results of a phase 3 study evaluating upadacitinib (Rinvoq, AbbVie) as a potential treatment of atopic dermatitis.

In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, dives into the impacts health care policies such as the Affordable Care Act and Medicaid expansion have on gender and sexual minority patients.

New regulations, latest absorption data, and updates on environmental and health impacts are shaping the world of photoprotection.

This week’s edition of The Mainstream Patient features stories about microcurrent facials, the psoriasis treatment journey, melanoma survivor stories, plus more.

ICYMI, some of this week’s featured content includes how to provide the best care to your gender and sexual minority patients, updates in the pipeline for psoriasis, a new drug on the horizon for cSCC, plus more.

Revance provides an update on the approval process for its injectable daxibotulinumtoxinA (DAXI) for the treatment of glabellar lines.

Dermavant has submitted a New Drug Application (NDA) to the FDA seeking approval for its novel topical for the treatment of mild, moderate, and severe plaque psoriasis in adult patients.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, discusses how to provide the best care for your gender and sexual minority patients.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of June.

AxisBiotix-Ps food supplement shows positive results in a recent consumer study evaluating its efficacy for psoriasis treatment.

Christopher Bunick, MD, PhD, associate professor of dermatology, Yale University and Dermatology Times® editorial advisory board member, weighs in on a recent report revealing certain batches of various sunscreen and after-sun care products were contaminated with benzene, a carcinogen.

We take a look back at what happened at the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis.

This episode will highlight some breaking news coming out of the sun protection world with a report by Valisure, which found in a recent test that 78 different sunscreen and after-sun care products were contaminated with benzene, a potential carcinogen.

David Light, founder and CEO of Valisure, the independent lab that discovered the presence of a human carcinogen in multiple brands and batches of sunscreen, sits down with Aesthetic Authority discuss the reports' findings and the impact this news will have on the sun protection industry.

David Light, founder and CEO of Valisure, the independent lab that discovered the presence of benzene in multiple brands and batches of sunscreen, sits down with Dermatology Times to discuss the reports' findings and the impact this news will have on the sun protection industry.

A recent test found various brands and batches of sunscreen and after-sun care products contained benzene, a known human carcinogen.